| __timestamp | Celldex Therapeutics, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 26684000 |
| Thursday, January 1, 2015 | 33837000 | 29829000 |
| Friday, January 1, 2016 | 35979000 | 39578000 |
| Sunday, January 1, 2017 | 25003000 | 43277000 |
| Monday, January 1, 2018 | 19269000 | 48645000 |
| Tuesday, January 1, 2019 | 15426000 | 52934000 |
| Wednesday, January 1, 2020 | 14456000 | 61349000 |
| Friday, January 1, 2021 | 20488000 | 127125000 |
| Saturday, January 1, 2022 | 27195000 | 136106000 |
| Sunday, January 1, 2023 | 30914000 | 133175999 |
Unleashing the power of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, HUTCHMED (China) Limited and Celldex Therapeutics, Inc. have taken different paths in optimizing these costs. From 2014 to 2023, HUTCHMED's SG&A expenses surged by approximately 400%, peaking at 136 million in 2022. In contrast, Celldex's expenses grew by a modest 50%, reaching around 31 million in 2023. This stark difference highlights HUTCHMED's aggressive expansion strategy, while Celldex appears to focus on lean operations. The data suggests that while HUTCHMED invests heavily in growth, Celldex prioritizes cost efficiency. As the pharmaceutical landscape evolves, these strategies will play a pivotal role in determining each company's market position.
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and HUTCHMED (China) Limited
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Celldex Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited
United Therapeutics Corporation or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Insmed Incorporated vs HUTCHMED (China) Limited Trends and Insights
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs HUTCHMED (China) Limited
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and HUTCHMED (China) Limited
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
Pharming Group N.V. vs HUTCHMED (China) Limited: SG&A Expense Trends
Bausch Health Companies Inc. or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: HUTCHMED (China) Limited vs Galapagos NV
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends